ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹4,482 Cr | ₹4,268 Cr | ₹855 Cr | ₹446 Cr | ₹1,156 Cr |
What is the latest Net Current Assets ratio of ZYDUS LIFESCIENCES ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹4,482 Cr |
Mar2022 | ₹4,268 Cr |
Mar2021 | ₹855 Cr |
Mar2020 | ₹446 Cr |
Mar2019 | ₹1,156 Cr |
How is Net Current Assets of ZYDUS LIFESCIENCES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹4,482 Cr | 4.99 | |
Mar2022 | ₹4,268 Cr | 399.40 | |
Mar2021 | ₹855 Cr | 91.64 | |
Mar2020 | ₹446 Cr | -61.41 | |
Mar2019 | ₹1,156 Cr | - |
Compare Net Current Assets of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹99,422.6 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
MANKIND PHARMA | ₹93,499.3 Cr | -2.7% | 1.6% | NA | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | 3.9% |
-1.7% |
85.2% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses